3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Recurrence
2
Neoplasm, Residual
2
Leukemia, Biphenotypic, Acute
2
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Down Syndrome
1
Blast Crisis
1
Interventions
fludarabine
3
Cyclophosphamide
3
obinutuzumab
2
acalabrutinib
2
ricolinostat
1
pirtobrutinib
1
idelalisib
1
ibrutinib
1
fludarabine phosphate
1
Rituximab
1
Mesna
1
Leukapheresis
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, B-Cell
×
blinatumomab
×
30 days
×
Clear all
No trials found.